Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluoxetine and premature ejaculation: a double-blind, crossover, placebo-controlled study

S M Haensel1, T M Klem, W C Hop

  • 1Department of Endocrinology and Reproduction, Erasmus University and Dijkzigt Academic Hospital, Rotterdam, The Netherlands. shaensel@euronet.nl

Journal of Clinical Psychopharmacology
|February 24, 1998
PubMed
Summary

This study found that fluoxetine effectively increased ejaculation latency in men with premature ejaculation (PE) and combined PE with erectile dysfunction (ED). The medication also improved objective erectile response without significant side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply by Authors.

The Journal of urology·2020
Same author

First trimester brain ventricle fluid and embryonic volumes measured by three-dimensional ultrasound with the use of I-Space virtual reality.

Human reproduction (Oxford, England)·2013
Same author

Human embryonic growth and development of the cerebellum using 3-dimensional ultrasound and virtual reality.

Reproductive sciences (Thousand Oaks, Calif.)·2013
Same author

Gestational sac fluid volume measurements in virtual reality.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2011
Same author

An innovative virtual reality technique for automated human embryonic volume measurements.

Human reproduction (Oxford, England)·2010
Same author

Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD.

Respiratory physiology & neurobiology·2010

Area of Science:

  • Pharmacology
  • Sexual Medicine
  • Clinical Trials

Background:

  • Premature ejaculation (PE) and erectile dysfunction (ED) are common male sexual dysfunctions.
  • Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine are sometimes used off-label for PE.
  • The efficacy and safety of low-dose fluoxetine for these conditions require further investigation.

Purpose of the Study:

  • To evaluate the effects of fluoxetine on sexual function, specifically ejaculation latency and erectile response, in men with PE and/or ED.
  • To compare fluoxetine's effects against a placebo in a controlled crossover study design.

Main Methods:

  • A prospective, double-blind, placebo-controlled, crossover study involving four groups: PE, PE/ED, ED, and healthy controls.
  • Subjects received fluoxetine (5-10 mg/day) or placebo for 4-week periods, separated by washout phases.

Related Experiment Videos

  • Evaluations included laboratory assessments of sexual function and home-based daily logs and nocturnal penile tumescence monitoring.
  • Main Results:

    • Fluoxetine significantly increased ejaculation latency in the combined PE and PE/ED groups (p = 0.007).
    • A significant increase in ejaculation latency was observed in the PE/ED group (p = 0.03).
    • Objective erectile response improved in all groups during laboratory assessment, though subjective effects were not significant. No major adverse events were reported.

    Conclusions:

    • Low-dose fluoxetine (5-10 mg/day) is effective in increasing ejaculation latency for men with premature ejaculation.
    • Fluoxetine demonstrates potential as a treatment for PE, with improvements in objective erectile function noted.
    • The study supports the use of fluoxetine for managing premature ejaculation, particularly when co-occurring with erectile dysfunction.